Skip to main content
Figure 1 | Breast Cancer Research

Figure 1

From: Buthionine sulfoximine sensitizes antihormone-resistant human breast cancer cells to estrogen-induced apoptosis

Figure 1

Intracellular glutathione (GSH) levels in wild-type MCF-7 cells and antihormone-resistant MCF-7:2A breast cancer cells. (a) MCF-7 and MCF-7:2A cells were seeded at 2 × 106 cells per 100 mm culture plates in phenol red RPMI media containing 10% fetal bovine serum (FBS) and phenol red-free RPMI media containing 10% 4× dextran coated charcoal-treated FBS (SFS), respectively, and after 24 h were treated with nothing (control) (white columns) or 100 μM buthionine sulfoximine (BSO) (black columns) for 24 h. Total cellular glutathione was measured using a Glutathione Colorimetric microplate assay kit, as described in Materials and methods. Columns, mean from three separate experiments; bars, ± standard error of the mean (SEM). **, p < 0.001 compared with control cells; #, p < 0.05 compared with MCF-7 control cells. Insert graph shows glutathione levels in MCF-7:2A cells over a 7-day period. (b) Quantitative real-time polymerase chain reaction (PCR) of glutathione sythetase (GS) (top left) and glutathione peroxidase 2 (GPx2) (bottom left) mRNA expression in MCF-7 and MCF-7:2A cells. **, p < 0.001 compared with MCF-7 control cells. Western blot analysis of GS protein expression in MCF-7:2A cells is also shown (top right).

Back to article page